Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / February / From Genome to Multiome
Omics Precision medicine Training and education Molecular Pathology Voices in the Community

From Genome to Multi-ome

Why scientists should rethink rare disease investigation methods

By Neil Ward 02/26/2026 Discussion 5 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Quiz
  • Poll
  • Top Institutions

Share

Objective:

To highlight the critical importance of a multi-omic approach in understanding and diagnosing rare diseases, emphasizing the urgency for improved diagnostic methods.

Key Findings:
  • Long-read sequencing significantly enhances the ability to detect complex genetic variants, as evidenced by recent studies.
  • The genome alone does not account for gene regulation and expression, which are crucial for understanding disease mechanisms.
  • Multi-omic approaches provide a more comprehensive view of rare disease mechanisms, linking genetic variants to clinical outcomes.
Interpretation:

A multi-omic framework is necessary to fully understand the complexities of rare diseases and improve diagnostic outcomes, ultimately benefiting patient care.

Limitations:
  • Fragmented approaches have historically limited insights into rare disease pathogenicity, making it difficult to form a complete understanding.
  • Traditional genomic analysis often overlooks non-coding variants that play significant roles in disease, presenting a challenge for accurate diagnosis.
Conclusion:

Integrating multiple 'omes through advanced sequencing technologies is vital for advancing rare disease research and improving patient outcomes, necessitating collaboration across disciplines.

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Neil Ward

General Manager EMEA at PacBio, based in Reading, UK.

More Articles by Neil Ward

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Turning Tides
Omics
Turning Tides

January 9, 2024

3 min read

A new study shows evidence for sustained human-to-human transmission of mpox since 2016

“Pop” Goes the Sensor
Omics
“Pop” Goes the Sensor

January 19, 2022

1 min read

A new device could help scientists identify signs of arrhythmia, heart attack, and cardiac fibrosis

Improving Risk Stratification
Omics
Improving Risk Stratification

February 3, 2022

1 min read

Two genes have been identified that may be linked to prostate cancer outcomes

The Ultimate Vision for Rare Disease
Omics
The Ultimate Vision for Rare Disease

February 28, 2022

1 min read

Genomics and computational pathology can take rare disease diagnostics to the next level

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.